BSE Live
Mar 31, 16:01Prev. Close
285.70
Open Price
286.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 31, 15:59Prev. Close
287.05
Open Price
288.50
Bid Price (Qty.)
289.70 (85)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Unichem Laboratories (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | -7.87 | 7.68 | -8.00 | 1.25 | 281.88 | |
Diluted EPS (Rs.) | -7.87 | 7.68 | -8.00 | 1.25 | 281.70 | |
Cash EPS (Rs.) | 3.94 | 18.46 | 2.10 | 10.02 | 369.88 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 379.52 | 383.11 | 375.99 | 388.15 | 392.63 | |
Book Value [InclRevalReserve]/Share (Rs.) | 379.52 | 383.11 | 375.99 | 388.15 | 392.63 | |
Dividend / Share(Rs.) | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | |
Revenue from Operations/Share (Rs.) | 133.93 | 159.64 | 128.46 | 137.50 | 95.16 | |
PBDIT/Share (Rs.) | -0.21 | 20.29 | 1.22 | 5.79 | -10.43 | |
PBIT/Share (Rs.) | -12.03 | 9.51 | -8.88 | -2.98 | -16.83 | |
PBT/Share (Rs.) | -12.32 | 9.32 | -9.06 | -3.07 | -17.28 | |
Net Profit/Share (Rs.) | -7.87 | 7.68 | -8.00 | 1.25 | 363.48 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | -0.15 | 12.70 | 0.94 | 4.21 | -10.95 | |
PBIT Margin (%) | -8.97 | 5.95 | -6.91 | -2.16 | -17.68 | |
PBT Margin (%) | -9.19 | 5.84 | -7.05 | -2.22 | -18.15 | |
Net Profit Margin (%) | -5.87 | 4.81 | -6.22 | 0.90 | 381.95 | |
Return on Networth / Equity (%) | -2.07 | 2.00 | -2.12 | 0.32 | 92.57 | |
Return on Capital Employed (%) | -3.01 | 2.43 | -2.33 | -0.75 | 91.07 | |
Return on Assets (%) | -1.77 | 1.73 | -1.86 | 0.29 | 82.39 | |
Total Debt/Equity (X) | 0.05 | 0.00 | 0.01 | 0.00 | 0.00 | |
Asset Turnover Ratio (%) | 0.30 | 36.03 | 29.89 | 31.93 | 21.57 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 4.43 | 3.51 | 4.32 | 6.83 | 7.46 | |
Quick Ratio (X) | 2.94 | 2.47 | 3.41 | 5.82 | 6.76 | |
Inventory Turnover Ratio (X) | 1.03 | 2.91 | 2.87 | 3.53 | 3.22 | |
Dividend Payout Ratio (NP) (%) | -50.80 | 52.07 | -60.28 | 481.83 | 1.28 | |
Dividend Payout Ratio (CP) (%) | 101.45 | 21.66 | 229.81 | 60.12 | 1.26 | |
Earnings Retention Ratio (%) | 150.80 | 47.93 | 160.28 | -381.83 | 98.72 | |
Cash Earnings Retention Ratio (%) | -1.45 | 78.34 | -129.81 | 39.88 | 98.74 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 1,860.09 | 2,120.07 | 875.44 | 1,178.64 | 1,339.06 | |
EV/Net Operating Revenue (X) | 1.97 | 1.89 | 0.97 | 1.22 | 2.00 | |
EV/EBITDA (X) | -1,251.83 | 14.84 | 102.28 | 28.92 | -18.26 | |
MarketCap/Net Operating Revenue (X) | 1.94 | 1.94 | 1.18 | 1.42 | 3.01 | |
Retention Ratios (%) | 150.80 | 47.92 | 160.28 | -381.83 | 98.71 | |
Price/BV (X) | 0.69 | 0.81 | 0.40 | 0.50 | 0.73 | |
Price/Net Operating Revenue | 1.94 | 1.94 | 1.18 | 1.42 | 3.01 | |
Earnings Yield | -0.03 | 0.02 | -0.05 | 0.01 | 1.27 |
06.02.2023
Unichem Labs Standalone December 2022 Net Sales at Rs 251.95 crore, up 1.47% Y-o-Y
06.02.2023
Unichem Labs Consolidated December 2022 Net Sales at Rs 302.50 crore, down 2.83% Y-o-Y
15.11.2022
Unichem Labs Standalone September 2022 Net Sales at Rs 265.64 crore, up 22.43% Y-o-Y
11.11.2022
Unichem Labs Consolidated September 2022 Net Sales at Rs 328.82 crore, up 13.13% Y-o-Y
06.02.2023
Unichem Labs Standalone December 2022 Net Sales at Rs 251.95 crore, up 1.47% Y-o-Y
06.02.2023
Unichem Labs Consolidated December 2022 Net Sales at Rs 302.50 crore, down 2.83% Y-o-Y
15.11.2022
Unichem Labs Standalone September 2022 Net Sales at Rs 265.64 crore, up 22.43% Y-o-Y
11.11.2022
Unichem Labs Consolidated September 2022 Net Sales at Rs 328.82 crore, up 13.13% Y-o-Y